Results
Rossari Biotech Q1 FY27 Results and Corporate Actions
Rossari Biotech reported Q1 FY27 consolidated revenue of ₹6,972 million and net profit of ₹350.95 million.
Board approved grant of 4000 ESOPs at ₹531 exercise price and allotment of 2500 equity shares
